An 2 Therapeutics Inc stock is traded at $4.03, with a volume of 12,709. It is up +1.77% in the last 24 hours and down -20.61% over the past month. AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
Previous Close:
$3.96
Open:
$3.99
24h Volume:
12,709
Relative Volume:
0.05
Market Cap:
$151.89M
Revenue:
-
Net Income/Loss:
-$34.55M
P/E Ratio:
-
EPS:
-$1.10
Net Cash Flow:
-$31.28M
1W Performance:
-11.15%
1M Performance:
-20.61%
6M Performance:
-13.44%
1Y Performance:
+259.38%
1-Day Range:
$3.90$4.10
1-Week Range:
$3.82$4.64
52-Week Range:
$1.00$7.19
An 2 Therapeutics Inc Stock (ANTX) Company Profile
Name
An 2 Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
(650) 331-9090Address
1300 EL CAMINO REAL, SUITE 100, MENLO PARK, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS